LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

Search

Stryker Corp

Closed

SectorHealthcare

363.69 2.57

Overview

Share price change

24h

Current

Min

353.71

Max

363.87

Key metrics

By Trading Economics

Income

-25M

859M

Sales

35M

6.1B

P/E

Sector Avg

47.188

77.256

EPS

3.19

Dividend yield

0.94

Profit margin

14.182

Employees

53,000

EBITDA

-108M

1.4B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+20.94% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.94%

2.33%

Market Stats

By TradingEconomics

Market Cap

-9.7B

137B

Previous open

361.12

Previous close

363.69

News Sentiment

By Acuity

23%

77%

57 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Stryker Corp Chart

Past performance is not a reliable indicator of future results.

Related News

30 Oct 2025, 20:36 UTC

Earnings

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31 Jul 2025, 20:42 UTC

Earnings

Stryker Lifts Guidance on Improving Tariff Outlook

1 May 2025, 20:56 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

5 Nov 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 Nov 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 Oct 2025, 20:21 UTC

Earnings

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.1B >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.06B >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

31 Jul 2025, 20:09 UTC

Earnings

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 Jul 2025, 20:09 UTC

Earnings

Stryker Sales >SYK

31 Jul 2025, 20:09 UTC

Earnings

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Net $884M >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Adj EPS $3.13 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

1 May 2025, 20:41 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1 May 2025, 20:11 UTC

Earnings

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1 May 2025, 20:10 UTC

Earnings

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1 May 2025, 20:05 UTC

Earnings

Stryker 1Q Adj EPS $2.84 >SYK

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

20.94% upside

12 Months Forecast

Average 430.6 USD  20.94%

High 455 USD

Low 392 USD

Based on 15 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

12

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

373.92 / 383.99Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

57 / 374 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat